Adrenocortical stem and progenitor cells: Unifying model of two proposed origins

Molecular and Cellular Endocrinology

Volumn 336, Issue 1-2, 2011, Pages 206-212

  Wood, Michelle A ^a   Hammer, Gary D ^a  

^a UNIVERSITY OF MICHIGAN   (United States)

Author keywords

Adrenal cortex; Adrenal development; Adrenocortical cells; Stem cells

Indexed keywords

BETA CATENIN; CORTICOTROPIN; GLUCOCORTICOID; INHIBIN; NUCLEAR RECEPTOR DAX 1; SOMATOMEDIN B; SONIC HEDGEHOG PROTEIN; STEROIDOGENIC FACTOR 1; TELOMERASE; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR GATA 6; TRANSCRIPTION FACTOR GLI1; TRANSCRIPTION FACTOR PBX1; WNT PROTEIN;

ADRENAL CORTEX; ADRENAL CORTEX CELL; ADRENAL CORTEX DEVELOPMENT; CELL DIFFERENTIATION; CELL LINEAGE; CELL PROLIFERATION; CELLULAR DISTRIBUTION; CYTOLOGY; HUMAN; MOLECULAR MECHANICS; NONHUMAN; ORGANOGENESIS; PREDICTION; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION; STEM CELL;

ADRENAL CORTEX; ANIMALS; CELL DIFFERENTIATION; CELL LINEAGE; HUMANS; MODELS, BIOLOGICAL; ORGANOGENESIS; STEM CELLS;

EID: 79952070297     PISSN: 03037207     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mce.2010.11.012     Document Type: Review

References (79)

1. Achermann J.C., Ito M., Hindmarsh P.C., Jameson J.L. A mutation in the gene encoding steroidogenic factor-1 causes xy sex reversal and adrenal failure in humans. Nat. Genet. 1999, 22:125-126.
2. Achermann J.C., Silverman B.L., Habiby R.L., Jameson J.L. Presymptomatic diagnosis of x-linked adrenal hypoplasia congenita by analysis of dax1. J. Pediatr. 2000, 137:878-881.
3. Assie G., Guillaud-Bataille M., Ragazzon B., Bertagna X., Bertherat J., Clauser E. The pathophysiology, diagnosis and prognosis of adrenocortical tumors revisited by transcriptome analyses. Trends Endocrinol. Metab. 2010, 21:325-334.
4. Babu P.S., Bavers D.L., Beuschlein F., Shah S., Jeffs B., Jameson J.L., Hammer G.D. Interaction between dax-1 and steroidogenic factor-1 in vivo: increased adrenal responsiveness to acth in the absence of dax-1. Endocrinology 2002, 143:665-673.
5. Bendall S.C., Stewart M.H., Menendez P., George D., Vijayaragavan K., Werbowetski-Ogilvie T., Ramos-Mejia V., Rouleau A., Yang J., Bosse M., Lajoie G., Bhatia M. Igf and fgf cooperatively establish the regulatory stem cell niche of pluripotent human cells in vitro. Nature 2007, 448:1015-1021.
6. Berthon A., Sahut-Barnola I., Lambert-Langlais S., de Joussineau C., Damon-Soubeyrand C., Louiset E., Taketo M.M., Tissier F., Bertherat J., Lefrancois-Martinez A.M., Martinez A., Val P. Constitutive beta-catenin activation induces adrenal hyperplasia and promotes adrenal cancer development. Hum. Mol. Genet. 2010, 19:1561-1576.
7. Beuschlein F., Looyenga B.D., Bleasdale S.E., Mutch C., Bavers D.L., Parlow A.F., Nilson J.H., Hammer G.D. Activin induces x-zone apoptosis that inhibits luteinizing hormone-dependent adrenocortical tumor formation in inhibin-deficient mice. Mol. Cell. Biol. 2003, 23:3951-3964.
8. Blanpain C., Horsley V., Fuchs E. Epithelial stem cells: turning over new leaves. Cell 2007, 128:445-458.
9. Calado R.T., Young N.S. Telomere maintenance and human bone marrow failure. Blood 2008, 111:4446-4455.
10. Campbell L.A., Faivre E.J., Show M.D., Ingraham J.G., Flinders J., Gross J.D., Ingraham H.A. Decreased recognition of sumo-sensitive target genes following modification of sf-1 (nr5a1). Mol. Cell. Biol. 2008, 28:7476-7486.
11. Chen W.Y., Lee W.C., Hsu N.C., Huang F., Chung B.C. Sumo modification of repression domains modulates function of nuclear receptor 5a1 (steroidogenic factor-1). J. Biol. Chem. 2004, 279:38730-38735.
12. Ching S., Vilain E. Targeted disruption of sonic hedgehog in the mouse adrenal leads to adrenocortical hypoplasia. Genesis 2009, 47:628-637.
13. Cui S., Ross A., Stallings N., Parker K.L., Capel B., Quaggin S.E. Disrupted gonadogenesis and male-to-female sex reversal in pod1 knockout mice. Development 2004, 131:4095-4105.
14. Else T. Telomeres and telomerase in adrenocortical tissue maintenance, carcinogenesis, and aging. J. Mol. Endocrinol. 2009, 43:131-141.
15. Else T., Giordano T.J., Hammer G.D. Evaluation of telomere length maintenance mechanisms in adrenocortical carcinoma. J. Clin. Endocrinol. Metab. 2008, 93:1442-1449.
16. Else T., Hammer G.D. Genetic analysis of adrenal absence: agenesis and aplasia. Trends Endocrinol. Metab. 2005, 16:458-468.
17. Else T., Theisen B.K., Wu Y., Hutz J.E., Keegan C.E., Hammer G.D., Ferguson D.O. Tpp1/acd maintains genomic stability through a complex role in telomere protection. Chromosome Res. 2007, 15:1001-1013.
18. Giordano T.J., Kuick R., Else T., Gauger P.G., Vinco M., Bauersfeld J., Sanders D., Thomas D.G., Doherty G., Hammer G. Molecular classification and prognostication of adrenocortical tumors by transcriptome profiling. Clin. Cancer Res. 2009, 15:668-676.
19. Giordano T.J., Thomas D.G., Kuick R., Lizyness M., Misek D.E., Smith A.L., Sanders D., Aljundi R.T., Gauger P.G., Thompson N.W., Taylor J.M., Hanash S.M. Distinct transcriptional profiles of adrenocortical tumors uncovered by DNA microarray analysis. Am. J. Pathol. 2003, 162:521-531.
20. Gummow B.M., Scheys J.O., Cancelli V.R., Hammer G.D. Reciprocal regulation of a glucocorticoid receptor-steroidogenic factor-1 transcription complex on the dax-1 promoter by glucocorticoids and adrenocorticotropic hormone in the adrenal cortex. Mol. Endocrinol. 2006, 20:2711-2723.
21. Gummow B.M., Winnay J.N., Hammer G.D. Convergence of wnt signaling and steroidogenic factor-1 (sf-1) on transcription of the rat inhibin alpha gene. J. Biol. Chem. 2003, 278:26572-26579.
22. Hammer G.D., Krylova I., Zhang Y., Darimont B.D., Simpson K., Weigel N.L., Ingraham H.A. Phosphorylation of the nuclear receptor sf-1 modulates cofactor recruitment: integration of hormone signaling in reproduction and stress. Mol. Cell 1999, 3:521-526.
23. Han V.K., Lu F., Bassett N., Yang K.P., Delhanty P.J., Challis J.R. Insulin-like growth factor-ii (igf-ii) messenger ribonucleic acid is expressed in steroidogenic cells of the developing ovine adrenal gland: Evidence of an autocrine/paracrine role for igf-ii. Endocrinology 1992, 131:3100-3109.
24. Han Y.G., Spassky N., Romaguera-Ros M., Garcia-Verdugo J.M., Aguilar A., Schneider-Maunoury S., Alvarez-Buylla A. Hedgehog signaling and primary cilia are required for the formation of adult neural stem cells. Nat. Neurosci. 2008, 11:277-284.
25. Hatano O., Takakusu A., Nomura M., Morohashi K. Identical origin of adrenal cortex and gonad revealed by expression profiles of ad4bp/sf-1. Genes Cells 1996, 1:663-671.
26. Hossain A., Li C., Saunders G.F. Generation of two distinct functional isoforms of dosage-sensitive sex reversal-adrenal hypoplasia congenita-critical region on the x chromosome gene 1 (dax-1) by alternative splicing. Mol. Endocrinol. 2004, 18:1428-1437.
27. Huang C.C., Miyagawa S., Matsumaru D., Parker K.L., Yao H.H. Progenitor cell expansion and organ size of mouse adrenal is regulated by sonic hedgehog. Endocrinology 2010, 151:1119-1128.
28. Ikeda Y., Lala D.S., Luo X., Kim E., Moisan M.P., Parker K.L. Characterization of the mouse ftz-f1 gene, which encodes a key regulator of steroid hydroxylase gene expression. Mol. Endocrinol. 1993, 7:852-860.
29. Ikeda Y., Shen W.H., Ingraham H.A., Parker K.L. Developmental expression of mouse steroidogenic factor-1, an essential regulator of the steroid hydroxylases. Mol. Endocrinol. 1994, 8:654-662.
30. Ingham P.W., McMahon A.P. Hedgehog signaling in animal development: Paradigms and principles. Genes Dev. 2001, 15:3059-3087.
31. Jeays-Ward K., Hoyle C., Brennan J., Dandonneau M., Alldus G., Capel B., Swain A. Endothelial and steroidogenic cell migration are regulated by wnt4 in the developing mammalian gonad. Development 2003, 130:3663-3670.
32. Jeyasuria P., Ikeda Y., Jamin S.P., Zhao L., De Rooij D.G., Themmen A.P., Behringer R.R., Parker K.L. Cell-specific knockout of steroidogenic factor 1 reveals its essential roles in gonadal function. Mol. Endocrinol. 2004, 18:1610-1619.
33. Jimenez P., Saner K., Mayhew B., Rainey W.E. Gata-6 is expressed in the human adrenal and regulates transcription of genes required for adrenal androgen biosynthesis. Endocrinology 2003, 144:4285-4288.
34. Kananen K., Markkula M., Mikola M., Rainio E.M., McNeilly A., Huhtaniemi I. Gonadectomy permits adrenocortical tumorigenesis in mice transgenic for the mouse inhibin alpha-subunit promoter/simian virus 40 t-antigen fusion gene: evidence for negative autoregulation of the inhibin alpha-subunit gene. Mol. Endocrinol. 1996, 10:1667-1677.
35. Keegan C.E., Hammer G.D. Recent insights into organogenesis of the adrenal cortex. Trends Endocrinol. Metab. 2002, 13:200-208.
36. Keegan C.E., Hutz J.E., Else T., Adamska M., Shah S.P., Kent A.E., Howes J.M., Beamer W.G., Hammer G.D. Urogenital and caudal dysgenesis in adrenocortical dysplasia (acd) mice is caused by a splicing mutation in a novel telomeric regulator. Hum. Mol. Genet. 2005, 14:113-123.
37. Kelly V.R., Hammer G.D. Lrh-1 and nanog regulate dax1 transcription in mouse embryonic stem cells. Mol. Cell. Endocrinol. 2010, 10.1016/j.mce.2010.10.003.
38. Kelly V.R., Xu B., Kuick R., Koenig R.J., Hammer G.D. Dax1 up-regulates oct4 expression in mouse embryonic stem cells via lrh-1 and sra. Mol. Endocrinol. 2010.
39. Khalfallah O., Rouleau M., Barbry P., Bardoni B., Lalli E. Dax-1 knockdown in mouse embryonic stem cells induces loss of pluripotency and multilineage differentiation. Stem Cells 2009, 27:1529-1537.
40. Kim A.C., Barlaskar F.M., Heaton J.H., Else T., Kelly V.R., Krill K.T., Scheys J.O., Simon D.P., Trovato A., Yang W.H., Hammer G.D. In search of adrenocortical stem and progenitor cells. Endocr. Rev. 2009, 30:241-263.
41. Kim A.C., Reuter A.L., Zubair M., Else T., Serecky K., Bingham N.C., Lavery G.G., Parker K.L., Hammer G.D. Targeted disruption of beta-catenin in sf1-expressing cells impairs development and maintenance of the adrenal cortex. Development 2008, 135:2593-2602.
42. King P., Paul A., Laufer E. Shh signaling regulates adrenocortical development and identifies progenitors of steroidogenic lineages. Proc. Natl. Acad. Sci. U.S.A. 2009, 106:21185-21190.
43. Komatsu T., Mizusaki H., Mukai T., Ogawa H., Baba D., Shirakawa M., Hatakeyama S., Nakayama K.I., Yamamoto H., Kikuchi A., Morohashi K. Small ubiquitin-like modifier 1 (sumo-1) modification of the synergy control motif of ad4 binding protein/steroidogenic factor 1 (ad4bp/sf-1) regulates synergistic transcription between ad4bp/sf-1 and sox9. Mol. Endocrinol. 2004, 18:2451-2462.
44. Lalli E., Sassone-Corsi P. Dax-1, an unusual orphan receptor at the crossroads of steroidogenic function and sexual differentiation. Mol. Endocrinol. 2003, 17:1445-1453.
45. Lee M.B., Lebedeva L.A., Suzawa M., Wadekar S.A., Desclozeaux M., Ingraham H.A. The dead-box protein dp103 (ddx20 or gemin-3) represses orphan nuclear receptor activity via sumo modification. Mol. Cell. Biol. 2005, 25:1879-1890.
46. Lewis A.E., Rusten M., Hoivik E.A., Vikse E.L., Hansson M.L., Wallberg A.E., Bakke M. Phosphorylation of steroidogenic factor 1 is mediated by cyclin-dependent kinase 7. Mol. Endocrinol. 2008, 22:91-104.
47. Lichtenauer U.D., Duchniewicz M., Kolanczyk M., Hoeflich A., Hahner S., Else T., Bicknell A.B., Zemojtel T., Stallings N.R., Schulte D.M., Kamps M.P., Hammer G.D., Scheele J.S., Beuschlein F. Pre-b-cell transcription factor 1 and steroidogenic factor 1 synergistically regulate adrenocortical growth and steroidogenesis. Endocrinology 2007, 148:693-704.
48. Lin L., Gu W.X., Ozisik G., To W.S., Owen C.J., Jameson J.L., Achermann J.C. Analysis of dax1 (nr0b1) and steroidogenic factor-1 (nr5a1) in children and adults with primary adrenal failure: ten years' experience. J. Clin. Endocrinol. Metab. 2006, 91:3048-3054.
49. Logan C.Y., Nusse R. The wnt signaling pathway in development and disease. Annu. Rev. Cell Dev. Biol. 2004, 20:781-810.
50. Looyenga B.D., Hammer G.D. Origin and identity of adrenocortical tumors in inhibin knockout mice: implications for cellular plasticity in the adrenal cortex. Mol. Endocrinol. 2006, 20:2848-2863.
51. Looyenga B.D., Hammer G.D. Genetic removal of smad3 from inhibin-null mice attenuates tumor progression by uncoupling extracellular mitogenic signals from the cell cycle machinery. Mol. Endocrinol. 2007, 21:2440-2457.
52. Looyenga B.D., Wiater E., Vale W., Hammer G.D. Inhibin-a antagonizes tgfbeta2 signaling by down-regulating cell surface expression of the tgfbeta coreceptor betaglycan. Mol. Endocrinol. 2010, 24:608-620.
53. Luo X., Ikeda Y., Parker K.L. A cell-specific nuclear receptor is essential for adrenal and gonadal development and sexual differentiation. Cell 1994, 77:481-490.
54. Matzuk M.M., Finegold M.J., Mather J.P., Krummen L., Lu H., Bradley A. Development of cancer cachexia-like syndrome and adrenal tumors in inhibin-deficient mice. Proc. Natl. Acad. Sci. U.S.A. 1994, 91:8817-8821.
55. Mesiano S., Mellon S.H., Jaffe R.B. Mitogenic action, regulation, and localization of insulin-like growth factors in the human fetal adrenal gland. J. Clin. Endocrinol. Metab. 1993, 76:968-976.
56. Mizusaki H., Kawabe K., Mukai T., Ariyoshi E., Kasahara M., Yoshioka H., Swain A., Morohashi K. Dax-1 (dosage-sensitive sex reversal-adrenal hypoplasia congenita critical region on the x chromosome, gene 1) gene transcription is regulated by wnt4 in the female developing gonad. Mol. Endocrinol. 2003, 17:507-519.
57. Morohashi K., Honda S., Inomata Y., Handa H., Omura T. A common trans-acting factor, ad4-binding protein, to the promoters of steroidogenic p-450s. J. Biol. Chem. 1992, 267:17913-17919.
58. Muscatelli F., Strom T.M., Walker A.P., Zanaria E., Recan D., Meindl A., Bardoni B., Guioli S., Zehetner G., Rabl W., et al. Mutations in the dax-1 gene give rise to both x-linked adrenal hypoplasia congenita and hypogonadotropic hypogonadism. Nature 1994, 372:672-676.
59. Nakae J., Kido Y., Accili D. Distinct and overlapping functions of insulin and igf-i receptors. Endocr. Rev. 2001, 22:818-835.
60. Niakan K.K., Davis E.C., Clipsham R.C., Jiang M., Dehart D.B., Sulik K.K., McCabe E.R. Novel role for the orphan nuclear receptor dax1 in embryogenesis, different from steroidogenesis. Mol. Genet. Metab. 2006, 88:261-271.
61. Nickerson P.A., Brownie A.C., Skelton F.R. An electron microscopic study of the regenerating adrenal gland during the development of adrenal regeneration hypertension. Am. J. Pathol. 1969, 57:335-364.
62. Peter M., Viemann M., Partsch C.J., Sippell W.G. Congenital adrenal hypoplasia: clinical spectrum, experience with hormonal diagnosis, and report on new point mutations of the dax-1 gene. J. Clin. Endocrinol. Metab. 1998, 83:2666-2674.
63. Phelan J.K., McCabe E.R. Mutations in nr0b1 (dax1) and nr5a1 (sf1) responsible for adrenal hypoplasia congenita. Hum. Mutat. 2001, 18:472-487.
64. Rainey W.E., Parker C.R., Rehman K., Carr B.R. The adrenal genetic puzzle: how do the fetal and adult pieces differ?. Endocr. Res. 2002, 28:611-622.
65. Sadovsky Y., Crawford P.A., Woodson K.G., Polish J.A., Clements M.A., Tourtellotte L.M., Simburger K., Milbrandt J. Mice deficient in the orphan receptor steroidogenic factor 1 lack adrenal glands and gonads but express p450 side-chain-cleavage enzyme in the placenta and have normal embryonic serum levels of corticosteroids. Proc. Natl. Acad. Sci. U.S.A. 1995, 92:10939-10943.
66. Sewer M.B., Waterman M.R. Adrenocorticotropin/cyclic adenosine 3',5'-monophosphate-mediated transcription of the human cyp17 gene in the adrenal cortex is dependent on phosphatase activity. Endocrinology 2002, 143:1769-1777.
67. Tissier F., Cavard C., Groussin L., Perlemoine K., Fumey G., Hagnere A.M., Rene-Corail F., Jullian E., Gicquel C., Bertagna X., Vacher-Lavenu M.C., Perret C., Bertherat J. Mutations of beta-catenin in adrenocortical tumors: activation of the wnt signaling pathway is a frequent event in both benign and malignant adrenocortical tumors. Cancer Res. 2005, 65:7622-7627.
68. Uotila U.U. The early embryological development of the fetal and permanent adrenal cortex in man. Anat. Rec. 1940, 76:183-203.
69. Urs A.N., Dammer E., Kelly S., Wang E., Merrill A.H., Sewer M.B. Steroidogenic factor-1 is a sphingolipid binding protein. Mol. Cell. Endocrinol. 2007, 265-266:174-178.
70. Urs A.N., Dammer E., Sewer M.B. Sphingosine regulates the transcription of cyp17 by binding to steroidogenic factor-1. Endocrinology 2006, 147:5249-5258.
71. Val P., Lefrancois-Martinez A.M., Veyssiere G., Martinez A. Sf-1 a key player in the development and differentiation of steroidogenic tissues. Nucl. Recept. 2003, 1:8.
72. Winnay J.N., Hammer G.D. Adrenocorticotropic hormone-mediated signaling cascades coordinate a cyclic pattern of steroidogenic factor 1-dependent transcriptional activation. Mol. Endocrinol. 2006, 20:147-166.
73. Xie K., Abbruzzese J.L. Developmental biology informs cancer: the emerging role of the hedgehog signaling pathway in upper gastrointestinal cancers. Cancer Cell 2003, 4:245-247.
74. Yang W.H., Heaton J.H., Brevig H., Mukherjee S., Iniguez-Lluhi J.A., Hammer G.D. Sumoylation inhibits sf-1 activity by reducing cdk7-mediated serine 203 phosphorylation. Mol. Cell. Biol. 2009, 29:613-625.
75. Zanaria E., Muscatelli F., Bardoni B., Strom T.M., Guioli S., Guo W., Lalli E., Moser C., Walker A.P., McCabe E.R., et al. An unusual member of the nuclear hormone receptor superfamily responsible for x-linked adrenal hypoplasia congenita. Nature 1994, 372:635-641.
76. Zubair M., Ishihara S., Oka S., Okumura K., Morohashi K. Two-step regulation of ad4bp/sf-1 gene transcription during fetal adrenal development: initiation by a hox-pbx1-prep1 complex and maintenance via autoregulation by ad4bp/sf-1. Mol. Cell. Biol. 2006, 26:4111-4121.
77. Zubair M., Oka S., Ishihara S., Morohashi K. Analysis of ad4bp/sf-1 gene regulatory region. Endocr. Res. 2002, 28:535.
78. Zubair M., Oka S., Parker K.L., Morohashi K. Transgenic expression of ad4bp/sf-1 in fetal adrenal progenitor cells leads to ectopic adrenal formation. Mol. Endocrinol. 2009, 23:1657-1667.
79. Zubair M., Parker K.L., Morohashi K. Developmental links between the fetal and adult zones of the adrenal cortex revealed by lineage tracing. Mol. Cell. Biol. 2008, 28:7030-7040.